Duration of detection of anti-BmR1 IgG4 antibodies after mass-drug administration (MDA) in Sarawak, Malaysia

Tropical Biomedicine

Volumn 29, Issue 1, 2012, Pages 191-196

  Noordin, R ^a   Muhi, J ^b,c   Md Idris, Z ^a   Arifin, N ^a   Kiyu, A ^b  

^a INSTITUTE FOR RESEARCH IN MOLECULAR MEDICINE INFORMM   (Malaysia)

^b Sarawak Health Department   (Malaysia)

^c Sabah Health Department   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFILARIAL AGENT; DIAGNOSTIC AGENT; HELMINTH ANTIBODY; IMMUNOGLOBULIN G; PARASITE ANTIGEN; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; AGED; ANIMAL; BLOOD; BRUGIA; CHILD; DRUG THERAPY; EPIDEMIOLOGY; HUMAN; IMMUNOLOGY; LYMPHATIC FILARIASIS; MALAYSIA; MALE; METHODOLOGY; MIDDLE AGED; NOTE; PRESCHOOL CHILD; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BRUGIA; CHILD; CHILD, PRESCHOOL; DRUG THERAPY; ELEPHANTIASIS, FILARIAL; FILARICIDES; HUMANS; IMMUNOGLOBULIN G; MALAYSIA; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; SEROEPIDEMIOLOGIC STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84859028521     PISSN: 01275720     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (12)

1. thMeeting of the Global Alliance to Eliminate Lymphatic Filariasis: A halftime review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases. Parasite Vectors 20;3(1): 100.
2. Fischer, P., Bonow, I., Supali, T., Rückert, P. & Rahmah, N. (2005). Detection of filarialspecific IgG4 antibodies and filarial DNA, for the screening of blood spots for Brugia malayi. Annals of Tropical Medicine & Parasitology 99: 53-60.
3. Jamail, M., Andrew, K., Junaidi, D., Krishnan, A.K., Faizal, M. & Rahmah, N. (2005). Field validation of sensitivity and specificity of rapid test for detection of Brugia malayi infection. Tropical Medicine and International Health 10: 99-104.
4. Lammie, P.J., Weil, G., Rahmah, N., Kaliraj, P., Steel, C., Goodman, D., Lakshmikanthan, V.B. & Ottesen, E. (2004). Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis-a multicenter trial. Filaria Journal 3: 9.
5. Melrose, W. & Rahmah, N. (2006). Use of Brugia Rapid dipstick and ICT test to map distribution of lymphatic filariasis in the Democratic Republic of Timor-Leste. Southeast Asian Journal of Tropical Medicine and Public Health 37: 22-25.
6. Ottesen, E.A. (2000). Editorial: The global programme to eliminate lymphatic filariasis. Tropical Medicine and International Health 5: 591-594.
7. Ottesen, E.A., Duke, B.O.L., Karam, M. & Behbehani, K. (1997). Strategies and tools for the control/elimination of lymphatic filariasis. Bulletin of the World Health Organization 75: 491-503.
8. Rahmah, N., Lim, B.H., Mehdi, R. & Nazmi, M.N. (2005). Treatment follow-up of Brugia malayi microfilaraemic and amicrofilaraemic individuals with serogical evidence of active infection. Malaysian Journal of Microbiology 1: 42-47.
9. Rahmah, N., Shenoy, R.K., Nutman, T.B., Weiss, N., Gilmour, K., Maizels, R.M. Yazdanbakhsh, M. & Sartono, E. (2003). Multicentre laboratory evaluation of Brugia Rapid dipstick test for detection of brugian filariasis. Tropical Medicine and International Health 8: 895-900.
10. Rahmah, N., Taniawati, S., Shenoy, R.K., Lim, B.H., Kumaraswami, V., Anuar, A.K., Hakim, S.L., Hayati, M.I.N., Chan, B.T., Suharni, M. & Ramachandran, C.P. (2001). Specificity and sensitivity of a rapid dipstick test (Brugia Rapid) in the detection of Brugia malayi infection. Transactions of the Royal Society of Tropical Medicine and Hygiene 95: 601-604.
11. Ramzy, R.M.R., El Setouhy, M., Helmy, H., Ahmed, E.S., Abd Elaziz, K.M., Farid, H.A., Shannon, W.D. & Weil, G.J. (2006). Effect of yearly mass drug administration with diethylcarbamazine and albendazole on brancroftian filariasis in Egypt: a comprehensive assessment. Lancet 367: 992-999.
12. World Health Organization (2005). Monitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at implementation unit level. Report No. WHO/CDS/CPE/CEE/2005.50. Geneva: World Health Organization.